IBM Maximo for Life Science

Xybion’s IBM Maximo Solutions team provides industry specific capabilities to support life science and pharmaceutical manufacturing business requirements.  We are industry-recognized specialists in implementing and supporting IBM Maximo when deployed in pharmaceutical manufacturing environments.  With expertise in FDA guidelines and regulatory compliance challenges such as 21 CFR part 11 (for support of electronic signatures and electronic audits), calibration of instruments, tools & measurement equipment and standards, support for asset-related CAPA processes as well as extensive computer system validation expertise, the Stelex™ EAM Solutions team provides a unique life science solution for IBM Maximo.

 
The Stelex team brings deep domain expertise on implementing, managing and maintaining your Maximo EAM in a the highly regulated life sciences industry sector.  Asset management is often tied to quality, compliance and risk management.  Management of assets that are heavily regulated as part of the overall life science drug development and manufacturing process include:
 
  • Laboratory Equipment maintenance records and service management
  • Manufacturing equipment validation
  • Systems (water) validation and testing
  • IT Asset management
  • Software validation and testing
  • Records management (audit trail)
 
Our specific offerings for Life Sciences include:
  • Audit trail management to meet 21CFR11 guidelines via our CAT™ application for Maximo
  • Process consulting for Maximo use in life science settings
  • Integration of Maximo with quality and compliance management applications and processes
   

 

Learn More about Xybion's Maximo Solutions

 

This email address is being protected from spambots. You need JavaScript enabled to view it.